Cargando…

Ursodeoxycholic acid protects against lung injury induced by fat embolism syndrome

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life‐threatening disease with a high mortality rate, which was a common complication of fat embolism syndrome (FES). Ursodeoxycholic acid (UDCA) has been reported to exert potent anti‐inflammatory effects under various condition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Fangfang, Li, Huafei, Xu, Xiaotao, Sun, Lingling, Gan, Ning, Wang, Aizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754031/ https://www.ncbi.nlm.nih.gov/pubmed/33145933 http://dx.doi.org/10.1111/jcmm.15985

Ejemplares similares

Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
por: Li, Chao, et al.
Publicado: (2020)

The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis
por: Lajczak‐McGinley, Natalia K., et al.
Publicado: (2020)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid
por: Coué, Marine, et al.
Publicado: (2019)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
por: Buryova, Halka, et al.
Publicado: (2013)

Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
por: Li, Yanyan, et al.
Publicado: (2023)

Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid
por: Tamai, Hideyuki, et al.
Publicado: (2023)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts
por: Huang, Liang, et al.
Publicado: (2023)

The protective effect of infliximab against carbon tetrachloride-induced acute lung injury
por: Kurt, Aysel, et al.
Publicado: (2016)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Salidroside Protects Against Influenza A Virus-Induced Acute Lung Injury in Mice
por: Lu, Rufeng, et al.
Publicado: (2021)

Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver
por: Farashbandi, Azam Letafat, et al.
Publicado: (2021)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model
por: Daruich, Alejandra, et al.
Publicado: (2021)

Glucosamine protects against radiation‐induced lung injury via inhibition of epithelial‐mesenchymal transition
por: Lei, Xiao, et al.
Publicado: (2020)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

The Effects of Aquaporin-1 in Pulmonary Edema Induced by Fat Embolism Syndrome
por: Zhang, Yiwei, et al.
Publicado: (2016)

Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression
por: Tronstad, Rune Rose, et al.
Publicado: (2022)

PKD2/polycystin-2 inhibits LPS-induced acute lung injury in vitro and in vivo by activating autophagy
por: Pan, Fan, et al.
Publicado: (2023)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
por: Choi, S. W., et al.
Publicado: (1991)

Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
por: Mahmoud, Amr A. A., et al.
Publicado: (2014)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
por: Pearson, Talima, et al.
Publicado: (2019)

Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy
por: Ughasoro, Maduka Donatus, et al.
Publicado: (2019)

Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
por: Oh, Ah-Reum, et al.
Publicado: (2016)

Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells
por: Talebian, Reza, et al.
Publicado: (2020)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
por: Subramanian, Subbaya, et al.
Publicado: (2020)

Potential effects of ursodeoxycholic acid on accelerating cutaneous wound healing
por: El-Hamoly, Tarek, et al.
Publicado: (2019)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

Ursodeoxycholic Acid May Inhibit Environmental Aging-Associated Hyperpigmentation
por: Moon, Ik Jun, et al.
Publicado: (2021)

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
por: Robles-Díaz, Mercedes, et al.
Publicado: (2021)

Butorphanol Promotes Macrophage Phenotypic Transition to Inhibit Inflammatory Lung Injury via κ Receptors
por: Luan, Guangxin, et al.
Publicado: (2021)

Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid
por: Wiemuth, Dominik, et al.
Publicado: (2013)

Ursodeoxycholic Acid but Not Tauroursodeoxycholic Acid Inhibits Proliferation and Differentiation of Human Subcutaneous Adipocytes
por: Mališová, Lucia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fuh5tfkp32480msj2756v23kpb